The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.

Azenta, Inc. (NASDAQ:AZTA), a company specializing in special industry machinery with a market capitalization of $2.46 billion, announced today that it has classified its B Medical (TASE:PMCN) Systems ...

Cigna said its medical loss ratio was 87.9% in Q4 2024, compared to 82.2% in the prior-year quarter. For the full-year 2024, MLR was 83.2%, which was still higher compared to the 81.3% its insurance ...

Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a $3.75 billion market cap company currently trading at $30.1 per share, recently reported a sale of company stock, according to a filing with ...

Furthermore, changes within the sales organization and the departure of the Chief Medical Officer introduce additional uncertainties that may impact future performance. These elements suggest a ...

The auto industry eked out a small increase in U.S. vehicle sales for 2024, helped by better availability on the new-car lot and a flurry of promotional deals in recent months. U.S. dealers sold ...

People 2025 is here, and a new year means new savings. Amazon, Sephora, Allbirds, and many other stores are having New Year’s sales, with markdowns on compact walking pads, Hollywood mom ...

Analysts project 2024 sales to near 16 million vehicles GM maintains sales crown with 2.7 million vehicles sold Stellantis and Tesla face challenges DETROIT, Jan 3 (Reuters) - U.S. new-car sales ...

Retailers are celebrating 2025 with massive New Year's sales. That means thousands of deals are available from Amazon, Walmart, and Target on TVs, kitchen appliances, vacuums, headphones ...

Investors are focusing on autonomous driving and other new technologies. By Jack Ewing Tesla sales fell slightly in 2024, the first annual decline in the company’s history, as rivals in China ...